SCIEX Launches CE Marked IVD-MS Analyzer for Hospitals and Diagnostic Laboratories in Europe
Continuing to rapidly expand its presence in the clinical diagnostics field, SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.
November 26, 2013
Continuing to rapidly expand its presence in the clinical diagnostics field, SCIEX, a global leader in analytical technologies, today announced the launch of its SCIEX IVD-MSTM Analyzer CE marked for general in vitro diagnostic use in Europe.*
The release of this mass spectrometry-based analyzer is in response to growing demand within hospitals and clinical diagnostic laboratories for faster, more accurate results than what is currently achievable with the most commonly used analyzers in the majority of diagnostic facilities today.
"We have redefined what a mass spectrometry analyzer is capable of doing for in vitro diagnostics," said Rainer Blair, President of SCIEX. "By combining the peace of mind of proven technology with the latest advancements in the user interface and integrated software development, we are making LC/MS/MS technologies as easy to use as ever in a clinical lab. Now available to a significant number of European clinical laboratories is the ability to improve the quality of in vitro diagnostic results while reducing costs compared to other technologies."
The new SCIEX IVD-MSTM Analyzer provides a combination of the high sensitivity and selectivity of mass spectrometry (MS) technology and the molecular separation power of liquid chromatography (LC) with a technician-friendly, intuitive interface.
SCIEX, which has been highly successful in the research (RUO) market for decades, has re-engineered its software application specifically for medical technologists, making the user interface more intuitive, simpler to navigate and ideal for new users in fast-paced clinical settings.
The new SCIEX ClearCoreTM MD Software provides streamlined data processing, reporting and review functionality. This will help make the adoption of LC/MS/MS for routine analysis significantly easier.
The ClearCore software enables quantitation and data exploration without the need for additional software packages. It provides simple method development tools with separate LC and MS method editors. It also provides customizable access to modules based on user security levels, including routine users, method developers, data reviewers and administrators, so personnel is only able to access approved modules. This software drives the workflow that utilizes the power of the analyzer.
The new IVD-MSTM Analyzer joins the company's growing line of in vitro diagnostic devices for certain European countries, including the SCIEX 3200MD CE-IVD series of MS systems - the API 3200MDTM and 3200MD QTRAP® LC/MS/MS systems - launched earlier in 2013. The new analyzer utilizes the company's state-of-the-art LC and MS technologies that have a proven track record with SCIEX customers.
The intended use of this regulatory-compliant device is to identify inorganic or organic compounds in human specimens for clinical use, providing routine diagnostic testing laboratories in certain countries in Europe with the ability to quantitate multiple trace level compounds in a single analysis with high confidence in the results. The company plans to extend its in vitro diagnostic solutions into other parts of the world in the future.
*Only available in select European regions at this time, not available in other countries. For more information contact your local SCIEX representative.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. Follow SCIEX on Twitter @ABSCIEX and on Facebook and LinkedIn